Ling‐Yuh Huw

Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer

Lisa Ryner, Yinghui Guan, Ron Firestein et al. · Clinical Cancer Research · 2015 · 111 citations · Full text

A multicenter, single‐arm, open‐label, phase 2 study of apitolisib (GDC‐0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)

Vicky Makker, Fernando O. Recio, Ling Ma et al. · Cancer · 2016 · 96 citations · Full text

Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort

Xiaoji Chen, Ching‐Wei Chang, Jill M. Spoerke et al. · Clinical Cancer Research · 2019 · 88 citations

Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer

Jiping Zha, Carol O’Brien, Heidi Savage et al. · Molecular Cancer Therapeutics · 2009 · 86 citations

Breast Oncology, Human Growth, Igf-ir Expression +19

Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E

Yi-Xin Wang, Baby Martin-McNulty, Ling‐Yuh Huw et al. · Atherosclerosis · 2002 · 79 citations

Inflammation, Thrombosis, Vascular Disease +12